DIP
EDIT icon

DT Investment Partners’s Editas Medicine EDIT Stock Holding History

DT Investment Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$134 Hold
54
– – ﹤0.01% 513
2025
Q4 		$111 Hold
54
– – ﹤0.01% 538
2025
Q3 		$188 Hold
54
– – ﹤0.01% 528
2025
Q2 		$119 Hold
54
– – ﹤0.01% 526
2025
Q1 		$63 Hold
54
– – ﹤0.01% 548
2024
Q4 		$69 Hold
54
– – ﹤0.01% 552
2024
Q3 		$185 Buy
+54
New +$235 ﹤0.01% 623

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DT Investment Partners's EDIT Position: Q1 2026 in Review

DT Investment Partners held its Editas Medicine (EDIT) position steady in Q1 2026 at 54 shares worth $134. The position accounts for ﹤0.01% of the portfolio, ranked #513.

DT Investment Partners first reported a position in EDIT in Q3 2024 and has held it in 7 quarters since. The position peaked at $188 in Q3 2025. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • DT Investment Partners held 54 shares of Editas Medicine worth $134 as of Q1 2026.
  • DT Investment Partners left its Editas Medicine share count unchanged in Q1 2026.
  • Editas Medicine made up ﹤0.01% of DT Investment Partners's portfolio in Q1 2026, its #513 holding.
  • DT Investment Partners first reported a position in Editas Medicine in Q3 2024 and has held it in 7 quarters since.
  • DT Investment Partners's Editas Medicine position peaked at $188 in Q3 2025.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on DT Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.